| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/27/2005 | WO2005007116A2 Artificial antigen presenting cell devices |
| 01/27/2005 | WO2004105775A8 Pharmaceutical composition comprising glucan derived from microalgae |
| 01/27/2005 | WO2004096757A8 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
| 01/27/2005 | WO2004092118A3 2-propylidene-19-nor-vitamin d compounds |
| 01/27/2005 | WO2003087374A9 Derivatives of the il-2 receptor gamma chain, their production and use. |
| 01/27/2005 | WO2003076565A3 Methods of using 46828, a human acyl-coa synthetase |
| 01/27/2005 | US20050020837 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 01/27/2005 | US20050020611 Phosphodiesterase inhibitor; antihistamines; antiallergens |
| 01/27/2005 | US20050020583 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 01/27/2005 | US20050020581 4H-quinazolinyl compounds; alkylation of a quinazoline with a 3-bromopiperidine-2,6-dione followed by alkylation with a heterocyclic alkyl compound; immunomodulators with increased solubility and chemical resistance to hydrolysis; alternatives to thalidomide treatment for autoimmune diseases |
| 01/27/2005 | US20050020579 Novel crystalline tricyclic triazolobenzazepine derivative |
| 01/27/2005 | US20050020562 Drugs; analgesics; anesthetics; antiarrhythmia agents; antiinflammatory agents ; incontinence; gastrointestinal disorders; neurodegenerative disease |
| 01/27/2005 | US20050020549 aqueous suspension; rhinitis therapy |
| 01/27/2005 | US20050020540 Biphenylcarboxylic amide derivatives as p38-kinase inhibitors |
| 01/27/2005 | US20050020504 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 01/27/2005 | US20050020498 Apo-2 ligand/trail formulations |
| 01/27/2005 | US20050020481 Ion channel modulating compounds and uses thereof |
| 01/27/2005 | US20050019837 Using glutamate decarboxylase concentration as diagnostic indicator of autoimmune and connective tissue disorders |
| 01/27/2005 | US20050019821 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/27/2005 | US20050019763 Isolated polypeptide of given sequence; expression vectors, host cells, antibodies, agonists, and antagonists; use in diagnosing, treating, or preventing various disorders |
| 01/27/2005 | US20050019754 Peptides of given sequence with immunogenic epitopes activating CD8+ class I major histocompatibility complex restricted cytotoxic T-lymphocytes for patients harboring latent HCMV infection in the absence of active viral replication; using enriched antigen presenting cells; vaccines |
| 01/27/2005 | US20050019426 Use of an aqueous or hydroalcoholic extract from bauhinia for the preparation of a composition |
| 01/27/2005 | US20050019417 stabilization of proteins, peptides or cells by fluidization of microparticles to form fluidized bed of microparticles comprising water soluble gel forming solid particles, then spraying coating with liquids comprising sugars and solvents, and drying |
| 01/27/2005 | US20050019347 Dna sequences and coding for hepatitis virus antigen |
| 01/27/2005 | US20050019344 Antigens; vaccines; isolated peptide |
| 01/27/2005 | US20050019340 Oil in water emulsion; immunology response; using cancer antigen |
| 01/27/2005 | CA2805464A1 Human antibody molecules for il-13 |
| 01/27/2005 | CA2804901A1 Human antibody molecules for il-13 |
| 01/27/2005 | CA2532323A1 Antibodies to cd44 vra and methods of use |
| 01/27/2005 | CA2528372A1 Inhibition of apoptosis-specific elf-5a ("eif-5a1") with antisense oligonucleotides and sirnas as anti-inflammatory therapeutics |
| 01/26/2005 | EP1500698A1 Cell with depression or deletion of the activity of protein participating in gdp-fucose transport |
| 01/26/2005 | EP1500658A1 Novel thiol derivative, process for producing the same and use thereof |
| 01/26/2005 | EP1500654A1 Benzoxazinone derivatives, the preparation and use thereof as medicaments |
| 01/26/2005 | EP1500643A1 Benzamide derivatives |
| 01/26/2005 | EP1500402A1 Cell death inhibitor |
| 01/26/2005 | EP1500400A1 Drug containing antibody composition |
| 01/26/2005 | EP1499886A1 Methods and compositions for inducing an immune response |
| 01/26/2005 | EP1499729A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use |
| 01/26/2005 | EP1499724A1 Derivatives of the il-2 receptor gamma chain, their production and use |
| 01/26/2005 | EP1499721A1 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription factors |
| 01/26/2005 | EP1499619A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof |
| 01/26/2005 | EP1499614A1 Adenosine a3 receptor modulators |
| 01/26/2005 | EP1499605A2 NF-KappaB INHIBITORS |
| 01/26/2005 | EP1499600A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 01/26/2005 | EP1499599A1 Substituted pyrazine derivatives |
| 01/26/2005 | EP1499585A1 Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition |
| 01/26/2005 | EP1499578A2 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| 01/26/2005 | EP1499358A1 Ph-sensitive polymer |
| 01/26/2005 | EP1499353A2 Antibodies that specifically bind to tl5 |
| 01/26/2005 | EP1499352A1 Recombinant anti-interleukin-9 antibodies |
| 01/26/2005 | EP1499349A2 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 01/26/2005 | EP1499347A2 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 01/26/2005 | EP1499345A2 Protein a compositions and methods of use |
| 01/26/2005 | EP1499343A1 A method of modulating cellular activity |
| 01/26/2005 | EP1499338A1 7-hydroxy-16alpha-fluoro-5-androsten-17-ones and 7-hydroxy-16alpha-fluoro-5-androstan-17-ones and derivatives thereof |
| 01/26/2005 | EP1499337A1 Immunotherapeutic and immunoprophylactic reagents |
| 01/26/2005 | EP1499336A2 Protease inhibitors |
| 01/26/2005 | EP1499330A1 Arsenic therapy for apls-type autoimmune lymph-oproliferative syndrome in mice and humans |
| 01/26/2005 | EP1499325A1 Methods and compositions for inhibition of irritation by disaccharide and metal ions |
| 01/26/2005 | EP1499322A1 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
| 01/26/2005 | EP1499320A1 Novel compounds |
| 01/26/2005 | EP1499316A1 (1-4-piperidinyl)benzimidazole derivatives useful as histamine h3 antagonists |
| 01/26/2005 | EP1499305A2 Use of ep4 receptor ligands in the treatment of il-6 involved diseases |
| 01/26/2005 | EP1499187A2 Immunostimulatory g,u-containing oligoribonucleotides |
| 01/26/2005 | EP1499186A1 Use of heme oxygenase-1 and products of heme degradation |
| 01/26/2005 | EP1296976B1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them |
| 01/26/2005 | EP1278749B1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO 3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 01/26/2005 | EP1239867B1 Methods for treating and preventing damage to mucosal tissue |
| 01/26/2005 | EP1058558B1 Adjuvated, live recombinant vaccines against influenza- and herpesviruse |
| 01/26/2005 | EP0996636B1 The ha-1 antigen |
| 01/26/2005 | EP0944592B1 Vitamin d3 derivatives |
| 01/26/2005 | EP0866691B2 Sublingual and buccal administration of selegiline |
| 01/26/2005 | EP0793717B1 Oral immunization with transgenic plants |
| 01/26/2005 | CN1571836A Human antibodies specific for interleukin 15 (IL-15) |
| 01/26/2005 | CN1571795A Synthesis of cyclosporin analogs |
| 01/26/2005 | CN1571794A Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 01/26/2005 | CN1571770A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/26/2005 | CN1571667A Inhibitors of dipeptidyl peptidase ó¶ |
| 01/26/2005 | CN1571660A Solid pharmaceutical agent formulation for a piperazine urea derivative |
| 01/26/2005 | CN1571657A Novel cyclosporin analog microemulsion preconcentrates |
| 01/26/2005 | CN1569880A SEA mutant gene and use for fusion protein thereof with ScFv gene |
| 01/26/2005 | CN1569197A Chinese medicinal soft capsule and preparing process thereof |
| 01/26/2005 | CN1569147A Tripterygium hypoglaucum contained transdermal plaster and its preparation |
| 01/26/2005 | CN1569088A 'Heiguteng' exract, its pharmaceutical composition and its use |
| 01/26/2005 | CN1569082A Medicinal capsule with functions of postponing senility and regulating immune system and preparation method thereof |
| 01/26/2005 | CN1569058A Innovative technique for processing aloe raw material with high stability |
| 01/26/2005 | CN1569054A Dripping pills of 'Xiao Chaihu' |
| 01/26/2005 | CN1569043A Coated micro capsule of lactic acid bacteria and its preparation |
| 01/26/2005 | CN1569042A Preparing and assaying method of staphylococcus aureus filtrate preparation |
| 01/26/2005 | CN1569023A Chitosan chewing tablet and its preparation method |
| 01/26/2005 | CN1569005A Enteric-coated formulation of glycyrrhizic acid and its salt and its preparing method |
| 01/26/2005 | CN1568992A Orally disintegrating tablet of loratadine and its preparation method |
| 01/26/2005 | CN1568991A Desloratadine diapersible tablet and its preparation method |
| 01/26/2005 | CN1568990A Dripping pills of cyproheptadine hydrochloride and its preparation method |
| 01/26/2005 | CN1568973A Composition of vitamin C and arginine and its application |
| 01/26/2005 | CN1186353C 17 peptide organic compound and its application |
| 01/26/2005 | CN1186322C Proline derivatives and use thereof as drugs |
| 01/26/2005 | CN1186057C Chinese medicinal pill for reinforcing kidney and strengthening yang, warming and recuperating qi and blood, and improving organism immunity |
| 01/26/2005 | CN1186039C Method for preparing Chinese medicine composition for treating ankylosing spondylitis complicated necrosis of femoral head |
| 01/26/2005 | CN1186032C Health-care food prepared from extracts of animals bone marrow and Chinese-medicinal materials |